Cancer/testis antigen 2

BE0010686ProteinHumansCTAG2

Cancer/testis antigen 2 (Humans) is a protein target in DrugBank. It is acted on by 1 drug in DrugBank.

Gene name
CTAG2
UniProtKB entry
O75638Swiss-Prot
Residues / weight
210 residues · 21,089 Da
Also known as
Autoimmunogenic cancer/testis antigen NY-ESO-2 · Cancer/testis antigen 6.2 · CT2 · CT6.2 · ESO2

Resolves to

Protein
UniProtO75638UniProt nameCTAG2_HUMAN
Gene
HGNCHGNC:2492NCBI Gene30848GeneCardsCTAG2
Pharmacology
KEGGhsa:30848
Drugs

What you can answer from here — as of October 31, 2023

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
2Clinical trialsTrials of drugs acting on it, by phase and status
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Cancer/testis antigen 2, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In